Kornitzer Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.6M Sell
122,159
-2,301
-2% -$220K 0.23% 96
2025
Q4
$12M Buy
124,460
+1,727
+1% +$168K 0.25% 91
2025
Q3
$11.7M Sell
122,733
-2,119
-2% -$195K 0.23% 105
2025
Q2
$10.9M Sell
124,852
-2,868
-2% -$243K 0.22% 118
2025
Q1
$11.5M Buy
127,720
+2,834
+2% +$254K 0.24% 112
2024
Q4
$9.98M Sell
124,886
-204,907
-62% -$17.7M 0.2% 147
2024
Q3
$29.7M Sell
329,793
-779
-0.2% -$65.5K 0.55% 41
2024
Q2
$26M Sell
330,572
-6,124
-2% -$502K 0.49% 45
2024
Q1
$29.3M Buy
336,696
+45,795
+16% +$3.91M 0.54% 40
2023
Q4
$24M Buy
290,901
+38,371
+15% +$2.92M 0.47% 48
2023
Q3
$19.8M Buy
252,530
+58,164
+30% +$4.87M 0.41% 51
2023
Q2
$17.1M Buy
194,366
+21,830
+13% +$1.88M 0.34% 80
2023
Q1
$13.9M Buy
172,536
+7,516
+5% +$613K 0.28% 106
2022
Q4
$12.8M Sell
165,020
-7,791
-5% -$631K 0.26% 113
2022
Q3
$14M Buy
172,811
+211
+0.1% +$19K 0.3% 96
2022
Q2
$15.5M Buy
172,600
+3,859
+2% +$391K 0.31% 91
2022
Q1
$18.7M Buy
168,741
+121
+0.1% +$12.8K 0.31% 109
2021
Q4
$17.4M Sell
168,620
-935
-0.6% -$108K 0.26% 146
2021
Q3
$21.3M Sell
169,555
-11,250
-6% -$1.46M 0.33% 101
2021
Q2
$22.4M Buy
180,805
+415
+0.2% +$52.1K 0.34% 104
2021
Q1
$21.3M Buy
180,390
+1,843
+1% +$216K 0.34% 105
2020
Q4
$20.9M Buy
178,547
+9,372
+6% +$1.03M 0.35% 88
2020
Q3
$17.6M Buy
169,175
+1,075
+0.6% +$108K 0.34% 91
2020
Q2
$15.4M Buy
168,100
+2,695
+2% +$258K 0.31% 117
2020
Q1
$14.9M Buy
165,405
+90,152
+120% +$9.59M 0.35% 100
2019
Q4
$8.54M Buy
75,253
+298
+0.4% +$32.7K 0.15% 197
2019
Q3
$8.14M Buy
74,955
+7,835
+12% +$817K 0.15% 192
2019
Q2
$6.54M Buy
67,120
+544
+0.8% +$49.7K 0.12% 223
2019
Q1
$6.06M Buy
66,576
+605
+0.9% +$54.1K 0.11% 231
2018
Q4
$6M Buy
65,971
+11
+0% +$1.03K 0.12% 213
2018
Q3
$6.49M Buy
65,960
+925
+1% +$85.5K 0.1% 228
2018
Q2
$5.57M Buy
65,035
+38,335
+144% +$3.2M 0.09% 230
2018
Q1
$2.14M Hold
26,700
0.04% 319
2017
Q4
$2.16M Sell
26,700
-440
-2% -$35.2K 0.04% 322
2017
Q3
$2.11M Buy
27,140
+2,515
+10% +$209K 0.04% 309
2017
Q2
$2.19M Sell
24,625
-25
-0.1% -$2.11K 0.04% 317
2017
Q1
$1.99M Buy
24,650
+275
+1% +$21.5K 0.04% 320
2016
Q4
$1.74M Buy
24,375
+3,824
+19% +$300K 0.03% 313
2016
Q3
$1.78M Sell
20,551
-2,050
-9% -$179K 0.03% 309
2016
Q2
$1.96M Sell
22,601
-199
-0.9% -$16.1K 0.04% 308
2016
Q1
$1.71M Buy
22,800
+17,900
+365% +$1.35M 0.03% 324
2015
Q4
$377K Buy
4,900
+200
+4% +$15.1K 0.01% 413
2015
Q3
$315K Buy
4,700
+43
+0.9% +$3.17K 0.01% 413
2015
Q2
$345K Sell
4,657
-300
-6% -$22.9K ﹤0.01% 417
2015
Q1
$387K Buy
+4,957
New +$376K ﹤0.01% 399

Other funds holding MDT

Kornitzer Capital Management's MDT Position: Q1 2026 in Review

Kornitzer Capital Management reduced its Medtronic (MDT) stake by 1.8% in Q1 2026, selling an estimated $220K and leaving 122,159 shares worth $10.6M. The position accounts for 0.23% of the portfolio, ranked #96.

Kornitzer Capital Management first reported a position in MDT in Q1 2015 and has held it in 45 quarters since. The position peaked at $29.7M in Q3 2024. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Kornitzer Capital Management held 122,159 shares of Medtronic worth $10.6M as of Q1 2026.
  • Kornitzer Capital Management sold 2,301 Medtronic shares in Q1 2026, an estimated $220K.
  • Medtronic made up 0.23% of Kornitzer Capital Management's portfolio in Q1 2026, its #96 holding.
  • Kornitzer Capital Management first reported a position in Medtronic in Q1 2015 and has held it in 45 quarters since.
  • Kornitzer Capital Management's Medtronic position peaked at $29.7M in Q3 2024.
  • 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Kornitzer Capital Management's 13F filing for Q1 2026, filed 30 Apr 2026.